Organ-On-a-Chip Market Growth Drivers, Industry Size, Development Strategy, Future Plans and Future Trends

Organ-on-a-chip Market Research Report: By Organ Type (Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip), By Application (Drug Discovery, Toxicology Research, Others) and By End-User (Pharmaceutical Companies, Research Organizations, Others) – Forecast to 2027Overview:The global organ-on-a-chip market is expecting a strong CAGR for the coming years during the forecast period covering 2019 to 2025.

A surge in the creation of better human disease models can also boost the prospect of this market.

The fetched data from these segments are expected to help the assessment of various strategic moves of this market.

By organ type, the global market can be segmented on the basis of lung-on-chip, heart-on-chip, intestine-on-chip, liver-on-chip, kidney-on-chip, human-on-chip, skin-on-chip, and blood-brain barrier-on-chip.

Other segments are also in line to impact the global healthcare sector.

North America is known for its superior infrastructure and benefits related to funding, owing to which the market may record easy growth in the coming years.

Market HighlightsAccording to MRFR analysis, Organ-On-a-Chip Market is expected to register a CAGR of 53% during the forecast period of 2019 to 2025 and was valued at USD 51.3 Million in 2018.Organs-on-chips (OOCs) are small plastic devices with biocompatible microfluidic chambers, which contain multiple live human cells in a 3D culture that simulate crucial physiological functions of body organs.

These cells are placed in an environment that artificially replicates aspects of the human body, such as morphology, movement, flow, electrical stimuli, and liquid gradients.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/8498The global organ-on-a-chip market is growing owing to various reasons, such as an increase in the number of collaborative sales agreements between pharmaceutical companies and university spin-offs and the availability of advanced models of OOCs in the market.

The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The organ-on-a-chip market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.Asia-Pacific is the fastest-growing region in the market.

This is mainly due to the increased application of OOCs for drug screening for the treatment of various chronic diseases and a supportive regulatory framework in Asia-Pacific.

Such favorable factors are expected to boost market growth during the forecast period.The organ-on-a-chip market in the Middle East & Africa has been divided into the Middle East and Africa.SegmentationThe global organ-on-a-chip market has been segmented based on organ type, application, and end-user.The global organ-on-a-chip market has been segregated, based on organ type, into lung-on-chip, heart-on-chip, liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain barrier-on-chip, human-on-chip, and others.The market based on application has been branched into drug discovery, toxicology research, and others.

Market InsightsAccording to the reports published by Market Research Future, the global lab-on-a-chip device market is projected to exhibit robust growth with registering a CAGR of 10% by the year 2023.

The lab-on-a-chip device brings diverse laboratory processes on a minimally sized integrated circuit and thus, eases the sample handling process and delivers results with excellent efficiency.Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6215With that, quick sampling with precise results within a short span of time can easily solve problems such as drug wastage as well as drug resistance.

Therefore, lab-on-a-chip offers optimization of the process and gains traction in various corners of the pharmaceutical sector.

Similarly, other factors such as multiple advantages of microfluidic technology, rise in demand for diagnostics, expanding global population with the prediction of significant growth opportunities, and technological advancements in laboratories have amplified the penetration and growth of the lab-on-chips market globally.

By the mode of technology, the market is segmented into microarrays, microfluidics, tissue biochip, and others.By the mode of the application, the market is segmented into genomics, proteomics, the point of care diagnostics, drug discovery, and others.Lastly, accounting on the end-user, the market is segmented as hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.Regional OutlookOn a geographical note, the global lab-on-a-chip device market has covered the main regions of America, Europe, Asia Pacific, and the Middle East & Africa.Among all, the Americas is the market leader and has an attractive lab-on-a-chip devices market growth owing to mounting advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.

According to stats by the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine.